Recruiting OBSERVATIONAL NCT05061953

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

Sponsor: Innodem Neurosciences

Updated 7 times since 2021 Last updated: Mar 1, 2023 Started: Oct 18, 2021 Primary completion: Oct 18, 2027 Completion: Oct 18, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05061953, this observational or N/A phase trial focuses on Multiple Sclerosis and remains actively recruiting participants. Sponsored by Innodem Neurosciences, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2023 — Jul 2024 [monthly]

Recruiting
Jan 2023 — Apr 2023 [monthly]

Recruiting
Sep 2022 — Jan 2023 [monthly]

Recruiting

▶ Show 2 earlier versions

Dec 2021 — Sep 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Oct 2021 — Dec 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innodem Neurosciences
Novartis Pharmaceuticals

Data source: Innodem Neurosciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada